Status:

COMPLETED

Efficacy of Nalmefene in Patients With Alcohol Dependence

Lead Sponsor:

H. Lundbeck A/S

Conditions:

Alcohol Dependence

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of the study is to evaluate the efficacy, safety and tolerability of nalmefene in the treatment of alcohol dependence.

Detailed Description

Alcohol dependence is a maladaptive pattern of alcohol use, leading to clinically significant impairment or distress, as manifested by at least three of a number of criteria such as tolerance, withdra...

Eligibility Criteria

Inclusion

  • In- and outpatients who:
  • had a primary diagnosis of alcohol dependence according to Diagnostic and Statistical Manual of Mental Disorders - Text revision (DSM-IV-TR) criteria
  • had had ≥6 HDDs in the 4 weeks preceding the Screening Visit
  • had had an average alcohol consumption at WHO medium risk level or above in the 4 weeks preceding the Screening Visit

Exclusion

  • The patient:
  • had a DSM-IV Axis I disorder other than alcohol dependence or nicotine dependence
  • had an antisocial personality disorder
  • had risk of suicide evaluated by the suicidality module of the Mini-International Neuropsychiatric Interview (MINI)
  • had a history of delirium tremens or alcohol withdrawal seizures
  • reported current or recent (within 3 months preceding screening) treatment with disulfiram, acamprosate, topiramate, naltrexone or carbimide, or with any opioid antagonists
  • reported current or recent treatment with antipsychotics or antidepressants
  • was pregnant or breast-feeding
  • Other protocol-defined inclusion and exclusion criteria may apply.

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2010

Estimated Enrollment :

598 Patients enrolled

Trial Details

Trial ID

NCT00811720

Start Date

December 1 2008

End Date

November 1 2010

Last Update

July 9 2013

Active Locations (39)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (39 locations)

1

AT001

Linz, Austria, 4020

2

AT004

Salzburg, Austria, 5020

3

AT003

Vienna, Austria, 1090

4

AT002

Vienna, Austria, 1230